U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

  1. Home
  2. Vaccines, Blood & Biologics
  3. Blood & Blood Products
  4. Approved Blood Products
  5. Kogenate FS
  1. Approved Blood Products

STN: BL 103332
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: Kogenate FS
Manufacturer: Bayer Corp, License #0008
Indications:

  • Control and prevention of bleeding episodes in adults and children with hemophilia A.
  • Peri-operative management in adults and children with hemophilia A.
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in children with hemophilia A and to reduce the risk of joint damage in children without pre-existing joint damage.
  • Routine prophylaxis to prevent or reduce the frequency of bleeding episodes in adults with hemophilia A.

Product Information

Supporting Documents

 

Back to Top